Stocks and Investing Stocks and Investing
Tue, March 7, 2023

Aydin Huseynov Initiated (ADVM) at Strong Buy and Held Target at $20 on, Mar 7th, 2023


Published on 2024-10-28 02:09:20 - WOPRAI, Aydin Huseynov
  Print publication without navigation


Aydin Huseynov of Ladenburg Thalmann, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $20 on, Mar 7th, 2023.

Aydin has made no other calls on ADVM in the last 4 months.



There are 2 other peers that have a rating on ADVM. Out of the 2 peers that are also analyzing ADVM, all agree with Aydin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daniil Gataulin of "Chardan Capital" Maintained at Hold with Decreased Target to $20 on, Friday, November 11th, 2022
  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $30 on, Friday, November 11th, 2022
Contributing Sources